Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Metformin, a widely prescribed medication for type 2 diabetes, may help protect individuals from the 2 most common types of ...

A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue—some as ...

After adjusting for demographics, no significant difference in cancer risk was observed for patients with vitiligo and patients without vitiligo.

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

The drug stands out as the only one of its kind, with the potential not only to prevent the onset of skin cancer but also to treat early-stage conditions in organ transplant patients. The ...

Knowing this helps your doctor decide which treatment you need. Unfortunately, Stage 4 melanoma skin cancer means the cancer is advanced. Treatment aims to control the cancer and help relieve symptoms ...

19, 2024 — A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes ... patients with metastatic melanoma treated with a ...

RNA from the COVID-19 infection in patients with certain metastatic cancers ... in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in early data from a phase 3 ...

Trials are now under way against cancers found everywhere from the skin and ovaries to the brain and lungs. After half a century of disappointing dead ends, promising results are starting to emerge.

Background: A 59-year-old female presented with a history of recurrent superficial bladder cancer. Since the initial diagnosis 12 years earlier, she had had 12 recurrences, all treated with ...